Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance

作者: Lisa J Harper , Daniela Elena Costea , Luke Gammon , Bilal Fazil , Adrian Biddle

DOI: 10.1186/1471-2407-10-166

关键词: Cancer researchCell biologyNeoplastic transformationCD44Stem cellCell cycleCell growthCell cycle checkpointG2-M DNA damage checkpointCell cycle phaseBiology

摘要: Background: Subsets of cells with stem-like properties have been previously isolated from human epithelial cancers and their resistance to apoptosis-inducing stimuli has related carcinoma recurrence treatment failure. The aim this study was investigate the mechanisms agents in both normal malignant epithelia. Methods: Cells fresh head neck carcinomas (n = 11), cell lines derived neck, prostate breast 7), oral mucosa 5), were exposed various (UV, Tumour Necrosis Factor, Cisplatin, Etoposide, Neocarzinostatin). Flow cytometry for CD44 epithelial-specific antigen (ESA) expression, colony morphology, tumour sphere formation rapid adherence assays used identify subset properties. Apoptosis, cycle expression checkpoint proteins assessed (Western Blot, qPCR). role G2-checkpoint regulators Chk1 Chk2 investigated by use debromohymenialdisine (DBH) siRNA. Results: In cancer biopsies a CD44high showed increased clonogenicity, significantly lower rate apoptosis, higher proportion G2-phase cycle. An inverse correlation between percentage apoptosis found. Pulse-chase iododeoxyuridine (IdU) demonstrated that high spent longer time G2, even un-treated controls. These expressed levels G2 proteins, release BDH or siRNA apoptosis. Low passage cultures keratinocytes also found contain showing similar pattern G2-block associated apoptotic resistance. Conclusions: data indicate show greater extended phase, property is not consequence neoplastic transformation. Targeting releases these makes them more prone implying an opportunity improved therapeutic approaches.

参考文章(45)
Muhammad Al-Hajj, Cancer stem cells and oncology therapeutics. Current Opinion in Oncology. ,vol. 19, pp. 61- 64 ,(2007) , 10.1097/CCO.0B013E328011A8D6
P. Kleihues, B. W. Stewart, World Cancer Report ,(2003)
Muhammad Al-Hajj, Michael W Becker, Max Wicha, Irving Weissman, Michael F Clarke, Therapeutic implications of cancer stem cells Current Opinion in Genetics & Development. ,vol. 14, pp. 43- 47 ,(2004) , 10.1016/J.GDE.2003.11.007
C. Hirschmann-Jax, A.E. Foster, G.G. Wulf, M.A. Goodell, M.K. Brenner, Revisiting the "Cdk-centric" view of the mammalian cell cycle. Cell Cycle. ,vol. 4, pp. 206- 208 ,(2005) , 10.4161/CC.4.2.1406
Carlo La Vecchia, Franca Lucchini, Eva Negri, Fabio Levi, Trends in oral cancer mortality in Europe Oral Oncology. ,vol. 40, pp. 433- 439 ,(2004) , 10.1016/J.ORALONCOLOGY.2003.09.013
D BRASH, W ZHANG, D GROSSMAN, S TAKEUCHI, Colonization of adjacent stem cell compartments by mutant keratinocytes. Seminars in Cancer Biology. ,vol. 15, pp. 97- 102 ,(2005) , 10.1016/J.SEMCANCER.2004.08.006
P A Baeuerle, O Gires, EpCAM (CD326) finding its role in cancer British Journal of Cancer. ,vol. 96, pp. 417- 423 ,(2007) , 10.1038/SJ.BJC.6603494
Michael F Clarke, John E Dick, Peter B Dirks, Connie J Eaves, Catriona HM Jamieson, D Leanne Jones, Jane Visvader, Irving L Weissman, Geoffrey M Wahl, None, Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Research. ,vol. 66, pp. 9339- 9344 ,(2006) , 10.1158/0008-5472.CAN-06-3126